“Targeting Neurodegeneration in Alzheimer’s Disease: A Comprehensive Evaluation of Andrographolide as a Potential Therapeutic Agent in the Management and Treatment of Cognitive Decline”, JIMP, vol. 1, no. 02, pp. 20–32, Aug. 2024, doi: 10.61920/jimp.v1i02.24.